Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating hypertension through renal artery denervation.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
